Citation: N. Burdin et P. Moingeon, Cancer vaccines based on dendritic cells loaded with tumor-associated antigens, CELL BIOL T, 17(2), 2001, pp. 67-75
Authors:
Elewaut, D
Brossay, L
Santee, SM
Naidenko, OV
Burdin, N
De Winter, H
Matsuda, J
Ware, CF
Cheroutre, H
Kronenberg, M
Citation: D. Elewaut et al., Membrane lymphotoxin is required for the development of different subpopulations of NK T cells, J IMMUNOL, 165(2), 2000, pp. 671-679
Authors:
Singh, N
Hong, S
Scherer, DC
Serizawa, I
Burdin, N
Kronenberg, M
Koezuka, Y
Van Kaer, L
Citation: N. Singh et al., Cutting edge: Activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype, J IMMUNOL, 163(5), 1999, pp. 2373-2377
Authors:
Gabaglia, CR
Pedersen, B
Hitt, M
Burdin, N
Sercarz, EE
Graham, FL
Gauldie, J
Braciak, TA
Citation: Cr. Gabaglia et al., A single intramuscular injection with an adenovirus expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with anIL-4-expressing vector increases disease susceptibility in B10.D2 mice, J IMMUNOL, 162(2), 1999, pp. 753-760
Citation: N. Burdin et al., Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis, EUR J IMMUN, 29(6), 1999, pp. 2014-2025